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Cover Letter
Response to reviewer comments 
 
The authors wish to thank the reviewers and editors for their helpful and constructive comments. 
We have highlighted major changes within the manuscript in blue. An itemized response to specific 
comments is provided below. 
 
 
Reviewers' comments: 
 
AE:  
This is a well-written review of critical aspects associated with using the gamma index in 
radiotherapy. Though largely discussed in the past, the topic is of interest to readers of Physica 
Medica who are likely to benefit from this review. However, the referees raised several questions 
with which I concur. I would encourage the authors to submit a revision that addresses the issues 
raised in the review process before this manuscript is considered for publication. 
 
Thank you for your comments, we have addressed the issues raised. 
 
 
Reviewer #1:  
 
The authors discuss the pitfalls and good practice in gamma index calculation. This is an interesting 
topic: the gamma index is widely used, yet sometimes a bit indiscriminately - often, details about the 
settings (global/local, threshold dose, etc.) are lacking in the scientific literature, and it is important 
to draw attention to these and other critical issues. A number of additional - less widely known - 
issues are addressed by calculations using an in-house software and some commercial systems are 
also evaluated. I find this paper very useful and interesting and would like to see it published. 
Although the structure does not adhere to the typical standards (methods, results etc.), I find it 
adequate and suitable for the present purpose, the text itself is very well written and enjoyable to 
read.  
 
Thank you for your constructive comments. We have made changes as you have recommended in 
the specific comments. 
 
I have one suggestion:  
With the Octavius 4D, I have the impression that the best agreement is always found for the coronal, 
worst for the sagittal plane. This can be explained if the depth dose curve is not quite correct or the 
extrapolation is slightly off. It might be interesting to include this issue, if it can be reproduced. 
 
Thank you for this interesting suggestion. We haven’t seen this and attempted to investigate this 
issue but could not reproduce it. For the purpose of this review we looked at the 3D volume gamma 
from the Octavius4D. The coronal measurement was using the OctaviusII octagonal phantom, not 
the coronal plane reconstruction in the Octavius4D. Further investigation at this time is slightly 
outside the scope of this review, there are a couple of potentially confounding factors that need to 
be considered to prove this. The number of points being evaluated would need to be controlled 
somehow. The dose gradients in the coronal plane would also need to be controlled in both planes. 
Possibly this could be achieved by creating a number of symmetric test volumes where the surface 
area seen in the coronal plane is the same as in the sagittal plane. 
 
Some minor points: 
 
*Detailed Response to Reviewers
Abstract, l.27: shedS light on 
Corrected, thank you. 
 
p.8 l.22: 2D plane vs 3D volume (leave out gamma analysis here as you do in the bullet before and 
after this one) 
 
Done as suggested, thank you. 
 
p.11, heading: Comparison against two (lower case) Commercial (capital) Software - I guess software 
is also plural, but most non-native readers will think this is strange - why not say "Software Systems" 
or "Implementation"? 
Corrected as suggested and have gone with “Software Systems”, thank you. 
 
 
Reviewer #3:  
General comments: 
The gamma index is commonly used for specific QA patient. The authors present the advantages and 
the disadvantages of this metrics. This review is of interest for the community as they give some 
recommendations for good practice. However I think this review could be improved before 
publication because some parameter studies are incomplete.  
 
Thank you for your constructive comments. We have made changes as you have recommended in 
the specific comments. 
 
 
Detailed comments: 
Page 3, line 16: Several point measurements are needed to derive an 1D measurement. In the 
context, I guess the authors mean point measurement instead of 1D. 
 
Corrected to say “single point (e.g. ionization chamber measurement, 1D (e.g. line profile), …” 
 
Page 3, line 26: Please add (rr) and (re) to define these quantities. 
 
These have now been defined. 
 
Page 4, line 11: I suggest to define the dose difference earlier (page 3, line 35).  
 
This has been defined earlier as suggested. 
 
Figure 1: I think it would be clearer to name differently the three DE points (DE1, rE1); (DE2, rE2); 
(DE3, rE3). And <GAMMA> could be expressed for those points. In addition <DELTA>D and DTA 
should be defined in the caption. And it is not clear if they represent the criteria or the value for 
points DE(rR), rR and DE(rE1). 
 
Page 4, line 26: The numbering could be 2.1 Formalism of the gamma index (page 3, line 24) and this 
section would become 2.2 Page 4, line 58: This paragraph should not be in the global and local 
section. I suggest to move this paragraph page 3, line 8. 
 
Modified as suggested. 
 
Page 5, line 49: In the second level, the authors wrote that for the 2 points in the vicinity of the 
reference point, <DELTA>r should be of opposite signs. <DELTA>r is a distance and is always positive. 
I think this is an error: <DELTA>D should be of opposite signs. 
 
Thank you, this mistake has been corrected. 
 
Page 7, line 10: I would appreciate the authors refer the following paper: 
Blanpain B, Mercier D. The delta envelope: a technique for dose distribution comparison. Med Phys. 
2009 Mar;36(3):797-808. 
This method is interesting and should be discussed in this review, here or in section 6. 
 
We have added a short discussion as requested. 
 
Page 7, lines 14-47: This paragraph is quite long and I am not convinced it provides additional useful 
information for the review. It could be shortened. 
 
We agree and this has been significantly shortened. 
 
Page 7, line 52: Ref 50 does not exist, I guess it should be 5. 
 
Thank you, it should be 5. We used Mendeley for referencing and this appears to have been an error 
with the citation for the paper by Wendling et al. All references have been carefully re-checked, 
however.  
 
Page 9, line19: Do the authors present results for the 2.5 or 5mm interpolated calculation grids? 
Please, specify at least in the table 1 caption. ? Why do you use a 1mm DTA? Compared to the pixel 
spacing, this choice is not recommended (as you state later in the review). In addition, why do you 
choose gamma analysis instead of dose difference to compare two calculated dose distributions? 
 
The results are presented for the 2.5mm grid. The reference to the 5mm grid is a typing error.  
 
We agree that dose difference would be appropriate; however we found the gamma index passing 
rate was the easiest metric in comparing the difference between the different interpolation 
techniques. For dose difference, we found using something like the mean difference or median 
difference was not sensitive and we needed to rely on visual inspection of the maps. We agree that 
the use of 1mm DTA contradicts later recommendations; we re-run the analysis with 0.1mm instead 
(this made negligible difference to the results). 
 
Page 10, line 1: Please, in equation 7, define xI = x0/2I. 
Added as suggested 
 
Page 10, line 10: Equation 8 is now <delta>r/xI. 
 
Agree, this has been corrected. 
 
Page 10, line 20: Ref 51 does not exist. Again I guess it should be 5. 
 
Corrected, same issue as mentioned above. 
 
Figure 4: Again what is the evaluated dose distribution? It looks like the 3%/1mm was plotted using 
x0 = 2,5mm and the 3%/3mm using 5mm. Please precise at least in the caption. 
 
To clarify x0 was 2.5mm in all cases, so the ratio distance criterion/pixel spacing (according to 
equation 8) will be different for 3mm and 1mm distance criterion. 
 
To make this figure clearer we have updated the caption. We hope that this has clarified this point 
for the reviewer. Please note that this is now Figure 6 in the revision. 
 
Page 10, line 55: The was copied. A word, probably "plan" is missing. 
 
Correct, the word “plan” has now been added 
 
Page 10, line 58: would exists. I think it should be written "would exist". 
 
Corrected, thank you. 
 
Figure 6: What is the grid resolution? What is the impact of grid resolution? 
 
The evaluated grid resolution was 2.5mm, however also added an additional graph side-by-side 
showing the similar trend if the evaluated distribution was 1.25mm resolution. Please note, this is 
now Figure 5 in the revision. 
 
Page 12, line 15: This comparison could be illustrated with results (for example % rates with or 
without interpolation for each solution: in-house and commercial). 
 
The results for this are indeed illustrated in Figure 8. 
 
Section 4: The study is performed for a single plan (data interpolation, search distance, comparison). 
Why do the authors use only one plan? A larger number of plans could have been included to state 
results. 
 
We agree with the reviewer that a single case is insufficient. The example we had was a fairly 
extreme error in a head & neck plan, we decided to also test a simple prostate plan (with very minor 
realistic errors included). We have found very consistent results between these two very contrasting 
cases (see updated Figure 4, 5, 6 and 8), for this reason we argue that these examples are sufficient 
for the purpose of the review. 
 
Page 13, line 25: What are the deliberate errors for those two plans? 
 
Description has been added in the test. These were single leaf MLC errors of 1, 2 and 5mm. 
 
 
Page 14, line 24: I am surprised by this statement. I would prefer suggest to use a detector with a 
good spatial resolution! Please, comment. 
 
This line wasn’t recommending a specific spatial resolution. Rather it was pointing out that if one has 
to use a detector array to reconstruct a 3D distribution then it should be done using the spacing of 
the detector array to avoid introducing sampling issues by trying to reconstruct a finer resolution 
distribution. We have added a line suggesting detector arrays with finer resolution would be more 
ideal but also being pragmatic in highlighting that such systems are not widely available, currently 
have limited field size and fairly expensive. 
 
Page 15, line 45: disadvantages instead of disadvantage. 
 
Corrected, thank you. 
 
EDITOR'S COMMENTS 
We will publish this good paper in EJMP as a review, after the major revision required by the 
Associate Editor: the two reviewers indicate some points where a better description is needed. 
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Abstract 
The gamma index (γ) is one of the most commonly used metrics for the verification of complex 
modulated radiotherapy. The mathematical definition of the γ is computationally expensive and 
various techniques have been reported to speed up the calculation either by mathematically refining 
the γ or employing various computational techniques. These techniques can cause variation in 
output with different software implementations. The γ has traditionally been used to compare a 2D 
measured plane against a 2D or 3D dose distribution. Recently, software algorithm and hardware 
improvements have led to the possibility of using measured 2D data from commercial detector 
arrays to reconstruct a 3D-dose distribution and perform a volumetric comparison against the 
treatment planning system (TPS). A limitation in this approach is that commercial detector arrays 
have so far been limited by their spatial resolution which may affect the accuracy of the 
reconstructed 3D volume and subsequently the γ calculation. Additionally, 3D versus 3D γ 
comparison adds a layer of complication in the calculation of the γ given the increase in the number 
of calculation points and the result cannot be as easily interpreted in the same way as 2D 
comparison. This review summarises and highlights the computational challenges of the γ 
calculation and sheds light on some of these issues by means of a bespoke MATLAB software to 
demonstrate the impact of interpolation, γ search distance, resolution and 2D and 3D calculations. 
Finally, a recommendation is made on the minimum information that should be reported when 
publishing γ results. 
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1 Introduction 
The gamma index (γ) is one of the most commonly used metrics for the verification of complex 
radiotherapy deliveries such as intensity modulated radiotherapy (IMRT) and volumetric modulated 
arc radiotherapy (VMAT) [1]. The metric has been widely accepted and is implemented into most 
commercial verification analysis software. By combining dose difference and distance-to-agreement, 
the γ provides the means for an efficient analysis which is particularly important within a busy 
clinical environment [2,3]. Its popularity can be seen in the number of times that it has been used in 
the scientific peer reviewed literature. In the Elsevier Scopus citation database it was found that the 
original γ paper [1] has been cited 1088 times in the literature since it was published, as of January 
2017. Of these, there were 978 original research articles; the remainder were composed of 81 
conference proceedings, 20 review papers and the remainder as book chapters, letters, or Editorials.  
 
The mathematical definition of the γ is computationally expensive and a full calculation can take a 
significant amount of time depending on the number of data points and the processing speed of the 
computer being used [4,5]. This has led to computational challenges where there have been various 
reports in the literature focused on either mathematically refining the γ or employing various 
computational techniques to speed up the process [4–8]. These various techniques can potentially 
cause variation in output with different software implementations. Often the exact technique 
employed to calculate the γ in commercial software is not well defined, with manufacturers typically 
referencing the original paper by Low et al [1], but the implementation having subtle variations. 
 
The γ has traditionally been used to compare a 2D measured plane against a 2D or 3D dose 
distribution. There have been quasi-3D commercial systems available [2,9–11]; however these have 
not constructed a true 3-dimensional dose distribution. Recently, software algorithm and hardware 
improvements have led to the possibility of using measured 2D data from commercial detector 
arrays to reconstruct a 3D-dose distribution and perform a volumetric comparison against the 
treatment planning system (TPS). A limitation in this approach is that commercial detector arrays 
have so far been limited by their spatial resolution which may affect the accuracy of the 
reconstructed 3D volume and subsequently the γ calculation due to under-sampling [12]. 
Additionally 3D versus 3D γ comparison adds an extra layer of complication in the calculation of the 
γ given the increase in the number of calculation points and therefore the limited speed of 
calculation and the result cannot be as easily interpreted in the same way as a 2D comparison. 
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This review article seeks to summarise and highlight the computational challenges of the gamma 
index calculation and shed light on some of these issues by means of bespoke in-house written 
MATLAB software to demonstrate the impact of interpolation, gamma index search distance, 
resolution and 2D and 3D calculations. 
 
2 Definition of the gamma index 
The gamma index combines dose difference and distance difference to calculate a dimensionless 
metric for each point in the evaluated distribution.  The reference dose distribution is generally 
taken as the ‘gold standard’, e.g. it could be the dose distribution that has been measured. In theory 
the distribution could be a single point (e.g. ionisation chamber measurement), 1D (e.g. a line 
profile), 2D (e.g. film measurement) or 3D (e.g. gel dosimetry, Monte Carlo simulation). The 
evaluated dose distribution is what is being compared. In most cases this will be the predicted TPS 
dose distribution that is being checked for accuracy in modelling the delivered dose. 
 
The most common passing criteria used is 3%/3mm which was originally recommended in the work 
by Low et al [1]. The γ was originally developed to compare measured water tank beam data against 
a treatment planning system algorithm. The criteria of 3%/3mm were used due to the limitations of 
TPS algorithms at the time, where particularly penumbra modelling was a source of uncertainty [1]. 
Because the γ takes into account dose difference and distance difference it was well-suited to the 
modulated fields in IMRT, however the criteria of 3%/3mm has persisted. 
 
2.1 Formalism of the gamma index 
The γ is calculated based on finding the minimum Euclidean distance for each reference point, see 
Figure 1 in conjunction with the following description. For each reference point in the dose 
distribution, calculate against each point in the evaluated distribution: 
 
1. the distance between reference to evaluated point:           
2. the difference between the reference and evaluated dose;           
Where    is the reference point,    is the evaluated point. The dose difference is calculated using 
Equation 1: 
 
                            
(1) 
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Where        is the dose at a point in the evaluated dose distribution,   , and        is reference 
point dose.  
 
Then for each point in the evaluated distribution, calculate the γ using Equation 2: 
 
          
          
   
 
          
   
 
            (2) 
 
Where    is the distance difference criterion and    is the dose difference criterion.  
 
The γ is then taken as the minimum value calculated over all evaluated points as shown in Equation 
3: 
 
                              
(3) 
 
The    and    criterion form an ellipsoid around the reference point as shown in Figure 1. If an 
evaluated point is located within this then the reference point will pass since γ will be < 1.  
 
For nomenclature it is standard to report the passing criteria in the format             ; e.g. 
3%/3mm. This standard nomenclature is used throughout this review. In order to eliminate dose in 
the out-of-field region where a large relative dose difference can be calculated and hence skew the γ 
result, it is typical to set a lower dose threshold below which the γ result is ignored. Therefore, it is 
common to limit the γ calculation to all points that are ≥10-20% of the maximum dose value within 
the dose distribution [13]. 
 
FIGURE 1. 
 
2.2 Global & local γ calculations 
Typically the γ calculations are categorised into two different types; local and global. The contrast 
between the two types is the way the dose difference is calculated. For a local γ, Equation 1 gives 
the definition for a local dose difference. For global gamma, Equation 1 has to be modified to 
become Equation 4: 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
5 
 
 
          
             
     
 
    (4) 
 
Where       is a normalisation dose value which can be defined as any value; for example, as the 
maximum dose within the reference dose distribution or a point selected in a high dose low gradient 
region. The two types of γ have advantages and disadvantages. The local γ will tend to highlight 
failures in high dose gradient regions and in low dose regions, whereas the global γ will tend to mask 
these errors but show the errors within the higher dose regions within the dose distribution. The 
choice of the γ calculation will depend on the needs of the test. The majority of published works 
within the reference list report global γ, although care should be taken in interpreting results, as it is 
often not defined which is used. 
 
3 The computing challenge of the gamma index 
The γ is a computationally expensive process due to the need to search all points in the evaluated 
distribution. This becomes more complex when comparing two 3D dose distributions. Ideally the γ 
would be calculated quickly to give a result within a reasonable time. The computer hardware used 
will have an impact on the speed of the γ calculation. Given previous limitations with computer 
technology, a number of studies in the literature have focussed on ways to mathematically decrease 
the calculation time of the γ. A common feature with manufacturer manuals is there is seldom 
detailed information on the way the γ calculation has been performed; with often the ‘go-to’ 
solution being to simply cite the original paper by Low et al. A true γ calculation can take from a few 
minutes up to potentially days for complex 3D dose distributions, which is clearly unacceptable from 
a clinical point of view [7].  
 
3.1 Mathematical techniques to refine/speed up the gamma index calculation 
A refinement of the γ was proposed by Depuydt et al [6]. In their work, the authors introduced a 
filter cascade of multiple levels that were designed to speed up the comparison.  The focus of this 
algorithm is whether or not a point passes or fails the γ criteria rather than calculating an absolute γ 
value for each point in the reference distribution. The algorithm employs 3 levels in the calculation. 
In the first level, the minimum γ is searched for within a limited search distance to reduce the 
calculation time. As soon as an evaluated point is found where          < 1 then the calculation is 
stopped and the algorithm moves on to the next reference point, starting at Level 1. If there are no 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
 
evaluated points where          < 1 then the algorithm moves on to Level 2. In the second level, the 
algorithm searches for at least 2 evaluated points in the vicinity of the reference point where the 
          for the two points is of opposite signs. In this scenario it is assumed that the evaluated 
distribution must intersect the region defined by the passing criteria and therefore the reference 
point is classified as passed. Failing this, the algorithm moves to the third and final level. In most 
cases, reference points rejected in Level 2 are because the evaluated points are truly outside the 
pseudo-space defined by the passing criteria. However, there may be rare occasions when the 
reference points should not have failed because of the discrete nature of the evaluated distribution. 
This is because it is possible for two discrete evaluated points at the outside edge of the passing 
region to produce a failed result, but interpolating between them means that there is an intersection 
with the passing region. Therefore Level 3 is designed to take these possibilities into account. If the 
reference point fails level 3 then it is classified as having failed the test.  
 
Chen et al [7] consider the possibility to speed up the search distance algorithm by using a fast 
Euclidean distance transform and predict a speedup of the order of tens of thousands for 3D γ 
calculations. Bakai et al [4] published a revision of the original γ formalism which considered 
gradient-dependent local acceptance thresholds. The actual number calculated by the Bakai method 
is called the χ index and is defined using Equation 5: 
 
  
             
                
 
    (5) 
 
In this method, one begins by calculating the local gradient for each point in the reference 
distribution,        , to build a gradient map or cube. Thus the comparison is performed in the 
dose domain. The numerator part of equation 5 means that this method only works when the 
reference and the evaluated dose distributions have the same array sizes. This formalism means that 
a χ distribution can be calculated efficiently using simple matrix operations which are optimised for 
speed in numerical analysis coding software such as MATLAB, or could be programmed in other 
languages using existing libraries and utilising multiple threads in the computer processing unit 
(CPU). The χ index retains the negative or positive sign, unlike the γ. The value of |χ| is also 
approximately equivalent to the γ [4]. 
 
Another similar technique to the χ index is the delta envelope proposed by Blanpain and Mercier 
[14]. The delta envelope is based on the union of the γ index ellipsoids centred on each reference 
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point. The envelope is effectively a maximum and minimum dose difference tolerance at each 
reference point. The ‘delta index’, δ, is calculated for each evaluated point checking if the dose 
difference to the reference point is within the max-min tolerance given by the δ envelope. Similar to 
the χ index, the δ can take a value of -1 to +1.  Because the delta envelope method reduces the 
analysis to a dose difference, the calculation is potentially quicker; 10s compared to 2 minutes γ 
index for 3D dose distributions [14]. One advantage of the delta envelope method is it avoids the 
uncertainty introduced by the resolution of the evaluated dose distribution where the gamma index 
can report different results whether this is interpolated or not (as discussed in more detail in section 
4). 
 
Wendling et al [5] developed a fast algorithm through speeding up the search routine by pre-sorting 
the distance from the reference point to evaluated points within a fixed search circle or sphere for 
2D and 3D respectively. The theory is that the search loop should be stopped when there is a low 
chance that evaluated data points will reach the minimal  . In their approach, the calculation starts 
at the reference point and increases outwards, terminating when the condition in Equation 6 is met 
[5]: 
 
          
   
               
     (6) 
 
The potential limitation of this technique is that there is potential for overestimation of the γ when 
dose differences are very large within the search region and then sharply drop off just outside this 
region. If an exhaustive search was performed in this scenario it would likely find the minimum γ in 
this region where the calculation has stopped. Ju et al [8] proposed a re-interpretation of the γ to 
avoid the need to interpolate the evaluated distribution to a finer grid, thus reducing the calculation 
time.  For 1D, 2D, and 3D distributions the evaluated distribution is divided into line segments, 
triangles and tetrahedral respectively. The closest distance between any reference point and these 
simplexes is calculated using matrix multiplication and inversion. The finding is that the method is as 
accurate as 16 times finer linear interpolation of the evaluated dose distribution with an order of 
~20 times speedup in calculation time. 
 
 
3.2 Future trends in computational techniques 
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As computer hardware continues to progress, the speed of the γ calculation will naturally continue 
to become quicker. In the last few years there have been innovative approaches to utilising the 
processing power provided by graphical processing units (GPU) which are commercially available 
with multiple cores that are in the region of 1000+. This allows for significant potential for parallel 
computing in areas such as Monte Carlo calculations or in this case, fast γ calculations. For the γ, it 
would be possible to utilise the GPU to perform the otherwise computer intensive task of the 
minimum distance search by searching and calculating γ for each reference in parallel. Gu et al [15] 
studied accelerated γ calculations by combining the geometric technique proposed by Ju et al [8] 
and the pre-sorting technique mentioned above by Wendling et al [5] and by implementing the 
calculation onto the GPU. They found a 45 – 70 times speedup of the calculation compared to the 
traditional implementation on the CPU. Persoon et al [16] found a speedup of 57 ± 15 for patient 
cases when using the GPU against the CPU.  
 
4 Evaluation of the software effect on the gamma index calculation using a Bespoke 
MATLAB® Software 
In order to investigate the different approaches that can be used to calculate γ, a software tool was 
written and implemented in MATLAB v2012a – 2014a (Mathworks Inc.). MATLAB uses some in-built 
functions for manipulation of matrices that can simplify the coding of the γ algorithm, but require 
the two compared datasets to have the same matrix size. This software was written so that it can 
accept two datasets with different resolution and matrix size, and by default is set up to do no 
interpolations on the reference dataset. This tool was implemented as a graphical user interface 
(GUI) for user-friendliness as shown in Figure 2. Some of the current features of the software are: 
 
 Able to handle 2D or 3D DICOM dose distributions 
 Datasets do not have to have the same resolution/matrix size as each other 
 Able to perform γ analysis in 2D plane vs 2D plane, 2D plane vs 3D volume, and 3D volume 
vs 3D volume  
 Specify whether to search the whole evaluated distribution, or limit the search to a user-
defined distance from each reference point 
 Perform global or local γ calculation, with ability to set dose difference and distance 
criterion. 
 Allows the user to set lower and upper dose thresholds (a yellow outline is given to visualise 
this; can be used e.g. to focus on a high dose region) 
 Allows the user to specify interpolation factors for either dataset 1 or dataset 2 
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 Allows the calculation of different γ metrics; % of points passing with γ<1, mean γ, median 
γ, maximum γ, or the minimum γ in the top X% pixels (e.g. minimum γ in the top 1% pixels; 
γ1%) 
 
FIGURE 2. 
By default, the dataset 1 was designated as the evaluated distribution, and dataset 2 was designated 
as the reference distribution. In the software, the in-built 2D and 3D interpolation functions (called 
interp2 and interp3 respectively) in MATLAB were used. The software was designed so that it is 
possible to interpolate either dataset 1 or 2 for investigative purposes (dataset 2 was always 
defaulted to have no interpolation unless the user specified otherwise). 
 
4.1 Which type of interpolation to use for the evaluated distribution? 
The interpolation options available in MATLAB were to use (1) a linear interpolation, (2) nearest 
neighbour, (3) cubic method or (4) spline method.  In order to test the different interpolation 
techniques available, a double 360° arc Head & Neck RapidArc™ treatment plan was calculated in 
the Varian Eclipse Treatment Planning System (TPS) using the Analytical Anisotropic Algorithm (AAA) 
v11 with a dose grid spacing of 1.25mm. It was then exported as a 2D DICOM plane with 1.25mm 
and 2.5mm. The 2.5mm grid calculation was then interpolated to a grid size of 1.25mm using the 
different interpolation techniques and compared directly against the 1.25mm dose calculation using 
the global γ and 1% / 0.1mm passing criteria. The % points passing with γ<1, and mean γ were 
quantified as well as visual inspection of the gamma map for each interpolation technique. No lower 
threshold was used for the γ calculation. 
 
Figure 3 shows the calculated gamma index maps for the four different interpolation techniques and 
Table 1 shows the % points passing γ<1 and mean γ results. It was found that the spline algorithm 
gave the best agreement to the non-interpolated data. For the purposes of this software the spline 
algorithm was therefore deemed to be optimal.  
 
FIGURE 3. 
TABLE 1. 
 
4.2 Impact of limiting the search distance on calculation time 
The gamma index calculation is a time consuming computational process. For example, performing a 
full gamma index comparison between two planes with a grid spacing of 2.5mm and 81 x 81 points 
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on a PC desktop with a quad-core Intel i7 4GHz CPU, and 16GB of RAM took ~380s to complete. A 
simple way to speed up the γ calculation significantly is to limit the search in the evaluated dose 
distribution to a set distance around each reference point. An interesting observation made in the 
study by Wendling et al [5] is that by setting a limited maximum search distance, it is only necessary 
to calculate the distance between a reference point and all the evaluated points bound by the 
search distance once; this can be defined as a 2D or 3D array,  . Similarly, it would then be possible 
to calculate the dose difference between the reference point and all the evaluated points which can 
be defined as an array   which has the same size as  . This significantly reduces computing 
overhead and makes it possible to perform matrix operations which are optimised for speed in 
programmes such as MATLAB by calculating all elements using parallelisation. 
 
To evaluate the impact of using a limited search distance, two very different plan scenarios were 
used. The first was to take the same Head & Neck RapidArc treatment plan described above was 
used with a dose grid of 2.5mm. The plan was copied and a collimator angle error of +5 degrees was 
introduced to the two arcs, such that a large range of failed and passing points with varying levels of 
dose gradient would exist, as shown in Figure 4. The second case was a simple prostate plan with 
subtle errors introduced to slightly disrupt the dose distribution. These were achieved by applying a 
gantry sag to the MLC positions in DICOM plan file, as described Carver et al [17], using Equation 7.  
 
                       
(7) 
 
Where MLCmod is the modified MLC position, MLCorig is the original position, and A is the specified 
maximum MLC position change (in this case we used 5mm), and θ is gantry angle. [17]. This led to 
realistic small deviations as shown in Figure 4.  
 
The error and normal plans were exported in DICOM format, as 2D planes with 81 x 81 points at 
2.5mm spacing, to be evaluated against each other in the MATLAB software.   
 
FIGURE 4. 
 
For global γ passing criteria of 3%/3mm, 3%/2mm, 3%/1mm, the search distance was set in 
increments until Equation 8 reached at least 5:  
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      (8) 
 
Where L was the search distance. As a baseline, full γ comparisons were calculated. The most 
informative parameter is the maximum calculated γ value as this will be affected by limited search 
distances. The calculation time was also recorded for each permutation. As    is varied, the physical 
search distance will have a different impact depending on the value chosen for   . Therefore the 
maximum γ was plotted against ; see Figure 5. In graph (a), it can be seen that for different passing 
criteria there was a consistent trend towards the maximum γ having no variation once   became 
≥3.0. This was consistent for both the simple plan and the extreme case. At this ratio, the maximum 
γ was the same as that where the entire evaluated distribution was searched. Even up to a higher  
= 5, the calculation time was still small at ~0.2s. This was performed for the evaluation distribution 
having a grid spacing of 2.5mm. To check if the trend is consistent for different resolution, the 
evaluated distribution of the prostate plan was re-calculated at 1.25mm spacing and the analysis 
repeated for 3%/2mm. As can be seen in Figure 5 (b) the trend is consistent for different evaluated 
dose resolution.  
 
FIGURE 5. 
 
 
4.3 The impact of the extent of data Interpolation 
A fundamental issue with the γ calculation is that the result will be influenced by the data point 
spacing of the evaluated dose distribution. There can be inaccuracies when the pixel spacing is 
equivalent to the distance criterion which can lead to overestimation of the γ. Previously Low et. al. 
[1] recommended that the pixel spacing should be      . More recently, Wendling et. al. concluded 
that the spacing should be of the order of        [5]. In order to achieve smaller point spacing, it is 
necessary to interpolate the evaluated dose distribution to a finer grid size.  
 
After confirming the spline algorithm for interpolation and speeding up the calculation by limiting 
the search distance, it was necessary to benchmark how much interpolation is needed. The same 
plans described in 4.2 were employed again. The normal plan was again set as the evaluated 
distribution and varying levels of interpolation were applied to this dataset. In MATLAB an integer 
interpolation factor,  , is specified. This changes the original spacing, x0 to xI according to Equation 9: 
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      (9) 
 
Where x0 was 2.5mm. For passing criteria of 3%/1mm, 3%/2mm, 3%/3mm,   was varied from 0 to 7 
in increments of 1. For each passing criteria the ratio was calculated according to Equation 10: 
 
  
  
  
  
   (10) 
 
For each calculation, the mean γ was calculated and the time taken for the calculation was recorded. 
The results of this are shown in Figure 6 where it can clearly be seen that the mean gamma varies 
sharply when the ratio of    and    are close to 1 and begins to stabilise by the time the ratio has 
become 10. This is in keeping with the recommendations by Wendling et al [5]. Up to this ratio, the 
calculation time was only of the order of 1 second and therefore as the default for further 
evaluations using the software the interpolation factor was set so   was ≥10. 
 
FIGURE 6. 
 
 
4.4 Comparison against two Commercial Software Systems 
The bespoke software was tested against two other established commercially available software; 
being the PTW Verisoft v5.1 package and IBA OmniPro v7.0. The same combination of the normal 
and error head & neck RapidArc plan was used. In order to test the software, the error plan was 
calculated and exported as 2.5mm, 5mm and 10mm dose grids to compare against the 2.5mm grid 
normal plan. Global γ comparisons were made using 3%/2mm passing criteria and no lower dose 
threshold. The mean gamma and % passing rates were compared. Figure 7 shows γ maps for the 
10mm grid spacing error plan against the normal plan.  
 
FIGURE 7. 
 
The top two images are from OmniPro and Verisoft respectively. It is clear that the OmniPro 
software prefers to plot the γ map as an intensity image where each pixel is given a discrete colour 
based on the γ. The Verisoft software uses a colour contour approach which is visually easier to 
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interpret. The two styles were replicated in MATLAB and the maps are given for the bespoke 
software below the respective commercial software maps. The figure shows good visual agreement 
in the γ maps between the bespoke software and the commercial packages. The comparison 
between the γ passing rate in the MATLAB software, OmniPro and Verisoft is shown in Figure 8. This 
shows very good agreement between the MATLAB and Verisoft calculations for all the different grid 
spacing of the error plan.  
 
FIGURE 8. 
 
Interestingly, if the MATLAB software is re-run with no interpolation setting, there is excellent 
agreement against OmniPro. This implies that Verisoft interpolates the evaluated dose distribution 
into a finer grid spacing, whereas OmniPro does not do this. This is a good example of how there can 
be variability in the implementation of the γ calculation. The above demonstration has focussed 
purely on the software side, however most commercial systems are designed to take into account 
the associated detector array configuration and therefore a more robust analysis would include an 
evaluation of the combined hardware and software. This aspect has been reported by Hussein et al 
where it has been shown that different commercial systems can give different gamma index results 
[2]. Agnew and McGarry have developed a tool to allow the quality assurance of gamma index 
software [18]. 
 
5 Gamma index calculation in 2D and 3D  
Traditionally the γ has been used to compare a 2D measured plane against a 2D or 3D dose 
distribution.  There is a growing trend in using 3D back-projected EPID based in-vivo systems and 
independent calculations using Monte Carlo [19] to perform 3D versus 3D γ comparison. DVH-based 
analysis techniques have been proposed, however the γ continues to be prevalent. Recently, 
software algorithm and hardware improvements have led to the possibility of using measured 2D 
data from commercial detector arrays to reconstruct a 3D-dose distribution and perform a 
volumetric comparison against the TPS. There are some issues that need to be considered when 
moving to a 3D volume γ. As there are more degrees of freedom and more data points, it is possible 
that 3D volume γ could give systematically better passing rates than 2D, and therefore the passing 
criteria need to be carefully reconsidered and whether they should be tightened.  Secondly, if using 
a detector array to reconstruct a 3D dose distribution and compare against the TPS, there are 
potential issues by the limited spatial resolution which may affect the accuracy of the reconstructed 
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3D volume depending on the type of interpolation algorithm and subsequently the γ calculation 
[12].  
 
5.1 Experimental demonstration 
These issues are demonstrated in an experiment conducted using the PTW OCTAVIUS® 4D , which is 
a commercial system that can use 2D measured data to reconstruct a 3D dose cube with 2.5mm  grid 
spacing [20–22]. Measurements were performed using the OCTAVIUS® Detector 729 and the high 
resolution OCTAVIUS® Detector 1000SRS inserted into the OCTAVIUS 4D.  The Detector 729 consists 
of a matrix of 729 cubic vented ionization chambers with 5 mm x 5 mm cross-section, spaced 10 mm 
centre-to-centre, giving a total area of 270 mm x 270 mm [23]. The Detector 1000SRS consists of a 
matrix of 977 liquid-filled ion chambers with 2.3 mm × 2.3 mm × 0.5 mm volume and 2.5 mm centre-
to-centre detector spacing in the central 55 mm x 55 mm area and 5 mm in the outer 110 mm x 110 
mm area. Traditional 2D coronal plane measurements were also separately performed using the 
OCTAVIUS Detector 729 within the OCTAVIUS II phantom for comparison. VERISOFT software version 
6.0 was used for all measurement acquisitions and analysis. 
 
Deliberate error tests for a prostate cancer 5-field IMRT and a single 360 RapidArc case were used 
following the same methodology as described by Hussein et al [2,24]. Both cases had single leaf MLC 
errors of 1, 2 and 5mm errors, respectively, added to the plan. In each case the plan with error was 
compared against the original unperturbed plan. For the 1000SRS array, the 3D reconstructed dose 
cylinder is limited to having 110 mm as its length and 55 mm radius. In order to maintain a 
consistent analysis, the same cylindrical volume was reconstructed using the Detector 729 
measurement. For the 2D coronal plane measurements using the OCTAVIUS 729 in the OCTAVIUS II 
phantom, the region of interest for the analysis was set to 110 mm x 110 mm.  
 
Predicted 2D and 3D γ pass rates were simulated in the bespoke MATLAB software by exporting the 
normal plan and error plan predicted dose distributions in DICOM format. The same cylinder and 
plane dimensions, above, were applied to the simulated 3D and 2D dose distributions respectively. 
For all evaluations, the global γ was used with passing criteria of 3%/2mm, and a 20% threshold. The 
γ results based on measurements were compared against the 3D volume predicted analysis. The 
concordance correlation coefficient, ρc, was used to assess agreement between the analyses. 
 
5.2 Experimental analysis 
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The impact of the 2D and 3D γ calculation can be significant depending on the spacing of detectors 
within an array and the way that it is used. A summary of mean percentage of points passing with 
γ<1 is given in Table 2. There was good agreement between the predicted γ for the 2D coronal plane 
and predicted 3D volume analysis (ρc>0.90). There was statistically strong agreement between the 
3D 1000SRS measured pass-rate and the 3D predicted pass-rate (ρc=0.93). In the case of a planar 
measurement using the sparsely arranged 2D-ARRAY 729 in the OCTAVIUS II (as the originally 
intended way for this array to be used for measurement) the γ passing rate was in reasonable 
agreement with the predicted 3D volumetric passing rate (ρc=0.81). However when the 2D-ARRAY 
729 was used in the OCTAVIUS 4D phantom to reconstruct a 3D dose distribution it gave the worst 
overall agreement at ρc = 0.34; the γ distributions in Figure 9 show that this is due to bands of failed 
points caused by artefacts. The reason for these is given Figure 10, which shows a comparison of 2D 
dose profiles (plotted as discrete points) for the RapidArc prostate normal plan measurement from 
the 3D reconstructed dose distributions using the 729 and 1000SRS array. The profile from the TPS 
predicted dose distribution is plotted for comparison. It is shown that, for the 729 array, there has 
been linear interpolation between points due to the low resolution which resulted in the dose points 
in those regions appearing to have an artificially lower dose than the TPS dose. This problem 
disappears when using the higher resolution 1000SRS detector array where the dose reconstruction is 
more accurate, leading to a statistically stronger agreement. Interestingly, reconstructing the 
Detector 729 measurement into a 10mm grid spacing dose distribution improved the agreement. 
This would suggest that a 3D distribution should be reconstructed at the native resolution of the 
detector array, rather than interpolating which can introduce sampling uncertainties. Ideally a finer 
resolution detector array, like the 1000SRS, should be used but there are currently limitations such as 
field size limitations, lack of wide availability, and cost of equipment. This experiment demonstrates 
that sparse detector arrays may increase measurement uncertainty when used to reconstruct 3D 
dose distributions and subsequently lead to some uncertainty with the gamma index calculation. 
This effect has also been reported by Xing et al [25] who compared the 3D γ between the OCTAVIUS 
4D and Sun Nuclear 3DVH™ and found average passing rate differences of -1.3% (max of 11.7%) due 
to the different interpolations by the two systems [25]. 
 
TABLE 2. 
FIGURE 9. 
FIGURE 10. 
 
6 Further considerations of the gamma index computation 
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It is common to report the results of a γ analysis as the percentage of points that achieved γ <1; i.e. 
the γ passing rate. The main characteristic of this metric is that it can condense a verification 
measurement into a single value; this is both the advantage and pitfall of this metric. If implemented 
carefully, it can be used to streamline QA by making it possible to choose decision thresholds for a 
passing rate, thereby reducing the analysis time [26–30]. The disadvantage is that the passing rate 
does not provide any details of where failed points are. Another disadvantage is that the γ itself is 
inherently an absolute metric, i.e. it provides no information on whether a failed point is due to 
positive or negative dose or distance fluctuations. For example, it is possible for there to be a failed 
point in an OAR region where the measurement is lower than the predicted dose by more than the 
dose difference criterion. In this case, the failed point is clinically acceptable as the OAR is receiving a 
lower than expected dose and the aim of radiotherapy is to keep dose to an OAR region as low as 
possible. Conversely, it is possible to have a failed point in a PTV region where the measured dose is 
higher which may also be acceptable. 
 
The use of the γ has been shown to have a weak correlation against clinically relevant metrics [31–
34]. However, recently Sumida et al [35] proposed a radiobiological γ which integrates tumour 
control probability (TCP) and normal tissue complication probability (NTCP). Essentially this works by 
perturbing a planned dose distribution at a voxel-by-voxel basis using a relative dose map measured 
by a detector array. A 3D γ is calculated on the normal versus perturbed dose distribution and those 
voxels with a γ>1 are weighted based on NTCP or TCP depending on whether they are in a target or 
normal tissue structure to give a radiobiological γ. The aim is that the weighting can help avoid the 
scenario above whereby the dose difference can be systematically at the level of the dose difference 
criterion but still pass. 
 
For the same passing criteria, different devices and software combinations exhibit varying levels of 
agreement with the MATLAB predicted γ analysis. As shown in this study, passing criteria of say 
3%/3mm may not give the same results for measurements by different QA systems [2]. Crowe et al 
report a method for calculating different tolerance thresholds for different passing criteria by 
comparing the sensitivity of different passing criteria against 3%/3mm [36]. It is also important to be 
aware that between different versions of the same software subtle changes to the gamma index 
calculation can cause a difference in the result and users should take care to re-perform 
benchmarking of the gamma index when any new software upgrade is released. 
 
The two types of γ calculation reported have advantages and disadvantages. The local γ will tend to 
highlight failures in high dose gradient regions and in low dose regions, whereas the global γ will 
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tend to mask these errors but show the errors within the higher dose regions within the dose 
distribution. The choice of the type of γ will depend on the need of the test. Most published works 
within the reference list report global γ. As Stojadinovic et al [37] point out, there is an infinite 
number of choices for the normalisation points for a global comparison whereas this choice is 
removed with a local comparison. Hussein et al previously investigated the impact of normalisation 
point choice by comparing analysis for a range of prostate and head & neck plans with deliberately 
introduced changes. They investigated the impact of selecting a point in a uniform region, maximum 
dose, or the mean dose within the PTV region and found no significant difference in the global γ 
passing rate, hence confirming the suitability of the global γ [24]. 
 
The suitability of the γ evaluation method in detecting clinically significant deviations has previously 
been questioned [31,38,39] and alternatives have been suggested [31,40–43]. However, the γ has 
been widely accepted and is implemented into most commercial software. The γ provides the means 
for an efficient analysis which is particularly important within a busy clinical environment [3]. It has 
also been used effectively within dosimetry audits of complex radiotherapy [44–48]. If one is 
performing a retrospective analysis of patient-specific QA in order to streamline the process, the γ 
provides a suitable means to explore trends over a period of time [49,50]. 
 
7 Conclusions 
A common factor in most modern commercial radiotherapy verification systems is the reliance on 
the γ method to provide the quantitative evaluation of the measured dose distribution against the 
TPS calculated dose distribution. The mathematical definition of the γ is straightforward; however it 
has presented computing challenges in terms of the speed of the calculation of the metric. The 
different computational approaches that are possible can produce variability in the calculation of the 
γ between different software. Two of these parameters are whether or not to interpolate the 
evaluated dose distribution such that the pixel spacing is sufficiently less than the distance criterion 
to avoid uncertainties in the gamma calculation, and whether to search the entire evaluated 
distribution or limit the search. Furthermore the impact of the 2D and 3D γ can be significant 
depending on the spacing of detectors within a commercial detector array and the way that it is 
used.  Given that various factors affect the gamma index calculation, as shown in this review, it is 
recommended that authors should report the following in published literature; the type of 
normalisation used (for example: to the maximum dose, a user selected point in a high dose low 
gradient region), whether the analysis was absolute or relative, whether local or global calculation 
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has been used, what (if any) low dose cut-off has been used, passing criteria as X%/Xmm, and the 
software used and version. 
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Table 1 Comparison of a head & neck dose distribution calculated at 2.5mm dose grid spacing in 
the TPS and interpolated to 1.25 mm spacing against the TPS dataset calculated with 
1.25mm dose grid spacing. Gamma index analysis of different interpolation techniques 
using global 1%/0.1mm, 0% threshold. 
Interpolation type Passing rate (%) Mean γ 
Spline 99.2 0.06 
Linear 97.9 0.14 
Cubic 99.0 0.08 
Nearest neighbour 79.0 0.73 
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Table 2 Summary of mean and minimum γ passing criteria for each system for the range of errors 
introduced. The concordance correlation coefficient, ρc, is also given assessing agreement 
with the predicted 3D volume γ pass-rate. 
 % detectors/pixels passing with γ<1 and ρc 
Mean min ρc Pearson ρ  
Predicted 
3D volume 98.8 92.4 N/A N/A 
2D coronal plane 98.6 91.8 0.98 0.99 
Measured 
OCTAVIUS729 2D coronal 97.8 86.9 0.81 0.99 
OCTAVIUS 1000 SRS 3D 
volume 
98.1 91.5 0.93 0.98 
OCTAVIUS729 3D volume; 
2.5mm grid 
97.2 94.6 0.34 0.47 
OCTAVIUS729 3D volume; 
10mm grid 
99.2 95.4 0.80 0.95 
 
 
Table 2
Figure 1 Schematic representation of the gamma index method in 1D. Adapted from Low et al 
(1998). The y-axis is Dose, D, and the x-axis is distance, r. The cross is the reference point 
and the blue line represents the evaluated dose distribution with the solid circles being 
discrete points along the line. The    and    criterion create an acceptance ellipse 
around the reference point. In this schematic and using Equation 2, point           
would have Γ > 1,         would be Γ <1, and         would be Γ = 1,        would be 
Γ < 1 (since it is inside the acceptance ellipse). Therefore the result of Equation 3 would 
be γ < 1 for the reference point. 
 
  
Figure 2 Screenshot of the gamma index calculation software implemented in MATLAB. 
 
Figure 3 Comparison of different Matlab interpolation algorithms; (a) spline, (b) linear, (c) cubic 
and (d) nearest neighbour. 
 
Figure 4 Gamma index map for the deliberate error distribution against the normal distribution, 
showing failed points expected in the 2.5mm pixel spacing reference distribution for (a) 
the head & neck VMAT plan with 5° collimator error (Dataset1), and (b) prostate IMRT 
with MLC sag due to gravity (Dataset2). 
 
Figure 5 (a) Comparison of the maximum γ as a function of varying the search distance for global 
gamma passing criteria 3%/3mm, 3%/2mm, 3%/1mm for Dataset 1 and Dataset 2. The 
evaluated dose grid spacing was 2.5mm. The average calculation time taken is plotted 
against the right axis. (b) Comparison repeated with evaluated dose grid spacing at 
1.25mm for Dataset 2, 3%/2mm. 
 
Figure 6 Comparison of the mean γ as a function of varying the interpolation factor for global 
gamma passing criteria 3%/3mm, 3%/2mm, 3%/1mm for Dataset 1 and Dataset 2. The x-
axis shows the ratio of the distance criterion divided by the pixel spacing (where 
x0=2.5mm in Equation 8). The calculation time is plotted against the right axis for each 
passing criteria. 
 
Figure 7 Gamma index map for the 10mm resolution reference distribution for Dataset 1 from (a) 
OmniPro, (b) Verisoft, (c) MATLAB plotted using the imagesc function, and (d) MATLAB 
plotted using the contourf function. 
Figure legends
 Figure 8 Comparison of % points passing with γ<1  between MATLAB, Verisoft and OmniPro 
analysis for reference Dataset 1 and 2 distributions with 2.5mm, 5mm and 10mm pixel 
spacing. In all cases the evaluated dose distribution had x0 = 2.5mm and analysis used 
global γ 3%/2mm with no lower dose threshold. (a) Dataset 1, where evaluated dose 
distribution was not interpolated in MATLAB; i.e. xI = 2.5mm, (b) Dataset 1, where 
evaluated dose distribution was interpolated in MATLAB; i.e. xI = 1.25mm, and similar 
respectively for Dataset 2 in figure (c) and (d).  
 
Figure 9 2D coronal planes. Top row: TPS, 1000SRS in OCTAVIUS 4D, OCTAVIUS 729 in OCTAVIUS 
4D, and 2D-ARRAY 729 in OCTAVIUS II dose distribution for the plan with 5mm MLC error.  
Bottom row: 3%/3mm γ distribution for the plan with 5mm MLC error in MATLAB 
predicted, OCTAVIUS 1000SRS, OCTAVIUS 729, and coronal 2D-plane 729 array.  
 
Figure 10 2D dose profile for the 3D reconstructed measured dose from the 729 and SRS-1000 
arrays compared against the TPS dose profile. 
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